Now tell me - how is it that they can say, in 2015, after a post-hoc analysis, that their agent works best in the sickest patients and now they are saying it works in the least sick CHF patients?
If that doesn’t raise flags, I don’t know what else could.
MSB Price at posting:
$2.31 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)